Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $246,340 |
Sells | 159 | $153,191,432 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Feb 2024 19:30 | VIR | Vir Biotechnology Inc | SCANGOS GEORGE A | Director | 26 Feb 2024 | Sale | 17,722 | 11.6534 | 206,522 | D |
28 Feb 2023 16:39 | VIR | Vir Biotechnology Inc | PANG PHILLIP | Chief Medical Officer | 27 Feb 2023 | Sale | 8,920 | 23.0029 | 205,186 | D |
23 Feb 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 21 Feb 2023 | Sale | 7,364 | 27.4893 | 202,431 | I |
07 Feb 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 03 Feb 2023 | Sale | 6,318 | 29.8517 | 188,603 | I |
21 Feb 2023 19:29 | VIR | Vir Biotechnology Inc | SCANGOS GEORGE A | President and CEO | 21 Feb 2023 | Sale | 6,474 | 28.8 | 186,451 | D |
25 Jan 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 23 Jan 2023 | Sale | 6,400 | 27.8012 | 177,928 | I |
30 Jun 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 28 Jun 2023 | Sale | 7,010 | 25.0958 | 175,922 | I |
29 Dec 2022 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 27 Dec 2022 | Sale | 6,850 | 25.5918 | 175,304 | I |
20 Apr 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 18 Apr 2023 | Sale | 6,953 | 25.1203 | 174,661 | I |
20 Feb 2024 21:02 | VIR | Vir Biotechnology Inc | SCANGOS GEORGE A | Director | 20 Feb 2024 | Sale | 16,872 | 10.2172 | 172,385 | D |
02 Dec 2022 17:51 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 01 Dec 2022 | Sale | 6,100 | 28.0825 | 171,303 | I |
24 Apr 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 20 Apr 2023 | Sale | 6,590 | 25.0603 | 165,147 | I |
26 Feb 2024 19:31 | VIR | Vir Biotechnology Inc | PANG PHILLIP | EVP & Chief Medical Officer | 22 Feb 2024 | Sale | 14,568 | 10.0456 | 146,344 | D |
14 Nov 2022 16:31 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 09 Nov 2022 | Sale | 5,269 | 27.2142 | 143,392 | I |
06 Jun 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 05 Jun 2023 | Sale | 5,197 | 27.3231 | 141,998 | I |
10 Jan 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 09 Jan 2023 | Sale | 4,974 | 26.1104 | 129,873 | I |
08 Jun 2023 16:30 | VIR | Vir Biotechnology Inc | PANG PHILLIP | Chief Medical Officer | 07 Jun 2023 | Sale | 5,000 | 25.9454 | 129,727 | D |
09 Feb 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 07 Feb 2023 | Sale | 4,442 | 28.9195 | 128,460 | I |
26 Feb 2024 19:34 | VIR | Vir Biotechnology Inc | HANLY ANN M. | EVP & Chief Technology Officer | 22 Feb 2024 | Sale | 12,296 | 10.0456 | 123,521 | D |
20 Feb 2024 21:02 | VIR | Vir Biotechnology Inc | SCANGOS GEORGE A | Director | 16 Feb 2024 | Sale | 10,878 | 10.2396 | 111,386 | D |
23 Jan 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 19 Jan 2023 | Sale | 4,037 | 25.9461 | 104,744 | I |
26 Feb 2024 19:30 | VIR | Vir Biotechnology Inc | SCANGOS GEORGE A | Director | 22 Feb 2024 | Sale | 10,028 | 10.0456 | 100,737 | D |
24 Feb 2023 20:34 | VIR | Vir Biotechnology Inc | SCANGOS GEORGE A | President and CEO | 24 Feb 2023 | Sale | 4,239 | 22.737 | 96,382 | D |
01 Feb 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 31 Jan 2023 | Sale | 3,316 | 28.8758 | 95,752 | I |
10 Sep 2024 16:28 | VIR | Vir Biotechnology Inc | NAPOLITANO JANET | Director | 09 Sep 2024 | Sale | 12,190 | 7.7959 | 95,032 | D |
02 Jun 2023 12:19 | VIR | Vir Biotechnology Inc | RAMASASTRY SAIRA | Director | 01 Jun 2023 | Sale | 3,500 | 25.67 | 89,845 | D |
23 Feb 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 21 Feb 2023 | Sale | 2,925 | 29.0755 | 85,046 | I |
03 May 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 01 May 2023 | Sale | 3,075 | 25.3047 | 77,812 | I |
24 Feb 2023 20:29 | VIR | Vir Biotechnology Inc | PANG PHILLIP | Chief Medical Officer | 23 Feb 2023 | Sale | 2,878 | 25.973 | 74,750 | D |
21 Feb 2023 19:24 | VIR | Vir Biotechnology Inc | PANG PHILLIP | Chief Medical Officer | 17 Feb 2023 | Sale | 2,802 | 25.288 | 70,857 | D |
02 Jun 2023 12:20 | VIR | Vir Biotechnology Inc | RICE STEVEN J. | Chief Administrative Officer | 01 Jun 2023 | Sale | 2,500 | 25.67 | 64,175 | D |
05 Jan 2023 17:00 | VIR | Vir Biotechnology Inc | SIGAL CHARLES ELLIOTT | Director | 03 Jan 2023 | Purchase | 2,500 | 25.597 | 63,992 | I |
05 Jan 2023 17:00 | VIR | Vir Biotechnology Inc | SIGAL CHARLES ELLIOTT | Director | 04 Jan 2023 | Purchase | 2,500 | 25.2545 | 63,136 | I |
25 May 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 24 May 2023 | Sale | 2,323 | 27.1155 | 62,989 | I |
20 Jun 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 15 Jun 2023 | Sale | 2,417 | 26.0195 | 62,889 | I |
09 Jan 2023 11:51 | VIR | Vir Biotechnology Inc | SIGAL CHARLES ELLIOTT | Director | 05 Jan 2023 | Purchase | 2,500 | 24.9582 | 62,396 | I |
21 Feb 2023 19:22 | VIR | Vir Biotechnology Inc | HORN HOWARD | CFO | 17 Feb 2023 | Sale | 2,424 | 25.288 | 61,298 | D |
25 May 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 23 May 2023 | Sale | 2,317 | 25.8385 | 59,868 | I |
31 Mar 2023 14:40 | VIR | Vir Biotechnology Inc | HANLY ANN M. | Chief Technology Officer | 30 Mar 2023 | Sale | 2,627 | 22.77 | 59,817 | D |
24 Feb 2023 20:35 | VIR | Vir Biotechnology Inc | HANLY ANN M. | Chief Technology Officer | 23 Feb 2023 | Sale | 2,302 | 25.973 | 59,790 | D |
28 Mar 2024 12:18 | VIR | Vir Biotechnology Inc | LEE SUNG | EVP & Chief Financial Officer | 27 Mar 2024 | Sale | 6,008 | 9.8875 | 59,404 | D |
24 Feb 2023 20:36 | VIR | Vir Biotechnology Inc | HORN HOWARD | CFO | 23 Feb 2023 | Sale | 2,248 | 25.973 | 58,387 | D |
02 Mar 2023 16:27 | VIR | Vir Biotechnology Inc | SIGAL CHARLES ELLIOTT | Director | 01 Mar 2023 | Purchase | 2,500 | 22.7262 | 56,816 | I |
21 Feb 2023 19:25 | VIR | Vir Biotechnology Inc | RICE STEVEN J. | Chief Administrative Officer | 17 Feb 2023 | Sale | 1,981 | 25.288 | 50,096 | D |
24 Feb 2023 20:28 | VIR | Vir Biotechnology Inc | RICE STEVEN J. | Chief Administrative Officer | 23 Feb 2023 | Sale | 1,795 | 25.973 | 46,622 | D |
12 Jun 2024 12:21 | VIR | Vir Biotechnology Inc | RAMASASTRY SAIRA | Director | 11 Jun 2024 | Sale | 4,000 | 10.9473 | 43,789 | D |
09 Feb 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 08 Feb 2023 | Sale | 1,300 | 29 | 37,700 | I |
16 Feb 2024 18:56 | VIR | Vir Biotechnology Inc | PANG PHILLIP | EVP & Chief Medical Officer | 16 Feb 2024 | Sale | 3,321 | 10.2396 | 34,006 | D |
07 Mar 2023 14:04 | VIR | Vir Biotechnology Inc | FRIEDL-NADERER JOHANNA | EVP & Chief Operating Officer | 03 Mar 2023 | Sale | 1,482 | 22.82 | 33,819 | D |
28 Feb 2023 16:39 | VIR | Vir Biotechnology Inc | PANG PHILLIP | Chief Medical Officer | 27 Feb 2023 | Sale | 1,400 | 23.5601 | 32,984 | D |
18 Nov 2022 16:30 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 16 Nov 2022 | Sale | 1,070 | 28.0066 | 29,967 | I |
02 Apr 2024 20:58 | VIR | Vir Biotechnology Inc | HANLY ANN M. | EVP & Chief Technology Officer | 01 Apr 2024 | Sale | 2,711 | 10.052 | 27,251 | D |
05 Jan 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 04 Jan 2023 | Sale | 1,000 | 25.468 | 25,468 | I |
30 Nov 2022 20:50 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 28 Nov 2022 | Sale | 885 | 28.0236 | 24,801 | I |
26 Apr 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 25 Apr 2023 | Sale | 961 | 25.2999 | 24,313 | I |
12 Jan 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 11 Jan 2023 | Sale | 900 | 25.9233 | 23,331 | I |
22 Nov 2022 18:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 21 Nov 2022 | Sale | 720 | 27.1313 | 19,535 | I |
09 Feb 2023 11:27 | VIR | Vir Biotechnology Inc | SATO VICKI L | Director | 08 Feb 2023 | Sale | 627 | 29 | 18,183 | D |
05 Jul 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 30 Jun 2023 | Sale | 700 | 25.11 | 17,577 | I |
13 Feb 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 09 Feb 2023 | Sale | 544 | 25.9904 | 14,139 | I |
27 Dec 2022 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 23 Dec 2022 | Sale | 321 | 26.0737 | 8,370 | I |
23 Feb 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 21 Feb 2023 | Sale | 242 | 26.95 | 6,522 | I |
09 May 2023 21:00 | VIR | Vir Biotechnology Inc | SVF ENDURANCE (CAYMAN) LTD | 10% | 05 May 2023 | Sale | 136 | 25.1032 | 3,414 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)